Literature DB >> 22458952

A review of the worldwide prevalence of vitiligo in children/adolescents and adults.

Christian Krüger1, Karin Uta Schallreuter.   

Abstract

BACKGROUND: Vitiligo is an acquired, idiopathic, and worldwide common depigmentation disorder with an estimated prevalence from 0.1 to 8%. These numbers are based on clinical population studies and field research examining inhabitants of geographically enclosed areas. Our aim was to collect all available data on the prevalence of vitiligo in the general population, paying particular attention to children/adolescent groups and adults.
MATERIALS AND METHODS: Screening of available literature and online databases using several key words.
RESULTS: We found more than 50 studies that used several methods and subgroups of the general population. The prevalence of vitiligo ranges from 0.06 to 2.28%, whereas this was 0.0-2.16% in children/adolescents populations.
CONCLUSIONS: The often cited prevalence of 8% could not be confirmed after excluding clinical patient populations. Accordingly, the worldwide prevalence of vitiligo ranges between 0.5 and 2%.
© 2012 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2012        PMID: 22458952     DOI: 10.1111/j.1365-4632.2011.05377.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  73 in total

Review 1.  Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.

Authors:  Navneet Arora; Ehraz Mehmood Siddiqui; Sidharth Mehan
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

2.  Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

Authors:  Lu-Mei Wang; Wan-Jiao Lu; Jing-Tao Yuan; Bi-Bing Zeng; Dan Li; Feng Zhang; Jun-Jie Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

3.  [Vitiligo: Clinical presentation and pathogenesis].

Authors:  M Schild; M Meurer
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

4.  Serum Zinc and Inflammatory Cytokines in Vitiligo.

Authors:  Eman Mostafa Sanad; Asmaa Adel El-Fallah; Ahmed Raad Al-Doori; Rehab Mohammed Salem
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

Review 5.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

6.  Consanguinity pattern and heritability of Vitiligo in Arar, Saudi Arabia.

Authors:  Dhaifallah A Alenizi
Journal:  J Family Community Med       Date:  2014-01

7.  Vitiligo and alopecia areata: apples and oranges?

Authors:  John E Harris
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

Review 8.  A central role for inducible heat-shock protein 70 in autoimmune vitiligo.

Authors:  Jeffrey A Mosenson; Jonathan M Eby; Claudia Hernandez; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2013-06-20       Impact factor: 3.960

9.  Reliability, Validity and Feasibility of the Vitiligo Extent Score (VES) and Self-Assessment Vitiligo Extent Score (SA-VES) Among Vitiligo Patients: A Cross-Cultural Validation.

Authors:  Pichanee Chaweekulrat; Narumol Silpa-Archa; Chalermkwan Apinuntham; Chayada Chaiyabutr; Chanisada Wongpraparut
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-07-28

Review 10.  Updates and new medical treatments for vitiligo (Review).

Authors:  David Emmanuel Kubelis-López; Natalia Aranza Zapata-Salazar; Salvador Luis Said-Fernández; Celia Nohemí Sánchez-Domínguez; Mauricio Andrés Salinas-Santander; Herminia Guadalupe Martínez-Rodríguez; Osvaldo Tomás Vázquez-Martínez; Uwe Wollina; Torello Lotti; Jorge Ocampo-Candiani
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.